“…Other barriers to testing have been described in the literature including access, insurance issues, other socioeconomic characteristics, patient risk perception, psychological well‐being and knowledge about/understanding of genetic testing, and primary care physician discussion of BRCA1/2 testing. It has been demonstrated that racial and ethnic minorities less frequently undergo genetic testing (Armstrong, 2005; Bowen et al, 2023; Chapman‐Davis et al, 2021; Hanson et al, 2023; Hong et al, 2023; Jones et al, 2017; Kurian et al, 2019, 2021). The current report is based on a consecutive population of patients seen as outpatients for ovarian cancer, but notably, the study population does lack diversity and reflects the general underrepresentation of minorities in clinical studies focusing on genetics.…”